Table 4.
Analysis | Antibody | # negatives | 95% CI | Cut Off Point (Se, Sp) |
---|---|---|---|---|
Mean +-2 Standard Deviations | S-IgG | 205 | (-0.192, 0.487) | 0.487 (92.45%, 95.12%) |
S-IgM | 206 | (-0.260, 0.739) | 0.739 (69.35%, 95.14%) | |
S-IgA | 206 | (-0.142, 0.185) | 0.185 (100%, 97.09%) | |
N-IgG | 207 | (-0.223, 0.874) | 0.874 (45.19%, 93.24%) | |
N-IgM | 207 | (-0.105, 0.701) | 0.701 (3.85%, 95.17%) | |
N-IgA | 207 | (-0.109, 0.345) | 0.345 (62.16%, 98.07%) | |
RBD-IgG | 203 | (-0.143, 0.264) | 0.264 (87.06%, 96.55%) | |
RBD-IgM | 203 | (-0.233, 0.681) | 0.681 (27.27%, 93.60%) | |
RBD-IgA | 203 | (-0.022, 0.057) | 0.057 (100%, 97.54%) | |
Analysis | Variable | Mean ± 3SD | Cut-off Point (Se,Sp) | |
Mean ± 3 Standard Deviations | S-IgG | 205 | (-0.361, 0.656) | 0.656 (82.08%, 98.05%) |
S-IgM | 206 | (-0.509, 0.989) | 0.989 (51.61%, 98.06%) | |
S-IgA | 206 | (-0.224, 0.267) | 0.267 (92.16%, 99.03%) | |
N-IgG | 207 | (-0.498, 1.149) | 1.149 (30.77%, 98.55%) | |
N-IgA | 207 | (-0.222, 0.458) | 0.458 (48.65%, 98.55%) | |
RBD-IgG | 203 | (-0.244, 0.365) | 0.365 (72.94%, 98.03%) | |
RBD-IgM | 203 | (-0.461, 0.910) | 0.910 (12.72%, 97.04%) | |
RBD-IgA | 203 | (-0.042, 0.077) | 0.077 (100%, 98.03%) |
Se, Sensitivity; Sp, Specificity.